| Prediction of posttraumatic stress disorder symptomatology after childbirth–A Croatian longitudinal study AS Imširagić, D Begić, L Šimičević, Ž Bajić Women and Birth 30 (1), e17-e23, 2017 | 56 | 2017 |
| The significance of Chlamydia trachomatis in urethritis and prostatitis - Differences in therapeutic approach - Croatian experience V Škerk, L Markovinović, Š Zekan, J Jakšić, S Židovec-Lepej, A Markotić, ... Journal of chemotherapy 21 (1), 63-67, 2009 | 26 | 2009 |
| Rosuvastatin‐induced rhabdomyolysis–Possible role of ticagrelor and patients’ Pharmacogenetic profile M Vrkić Kirhmajer, V Macolić Šarinić, L Šimičević, I Ladić, K Putarek, ... Basic & clinical pharmacology & toxicology 123 (4), 509-518, 2018 | 25 | 2018 |
| Multivariate analysis of predictors of depression symptomatology after childbirth A Srkalović Imširagić, D Begić, I Sarajlić Vuković, L Šimićević, T Javorina Psychiatria Danubina 26 (suppl 3), 416-421, 2014 | 19 | 2014 |
| Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review N Božina, L Ganoci, L Simičević, K Gvozdanović, I Klarica Domjanović, ... Arhiv za higijenu rada i toksikologiju 72 (2), 128-128, 2021 | 15 | 2021 |
| Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population V Krasniqi, A Dimovski, H Qorraj Bytyqi, A Eftimov, L Šimičević, N Božina Arhiv za higijenu rada i toksikologiju 68 (3), 180-184, 2017 | 13 | 2017 |
| DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols N Božina, I Bilić, L Ganoci, L Šimičević, S Pleština, L Lešnjaković, ... British journal of clinical pharmacology 88 (5), 2190-2202, 2022 | 12 | 2022 |
| Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of … I Merćep, I Radman, V Trkulja, T Božina, L Šimičević, E Budimir, L Ganoci, ... European journal of clinical pharmacology, 1-10, 2022 | 10 | 2022 |
| Use of pharmacogenomics in elderly patients treated for cardiovascular diseases IM Nada Božina, Majda Vrkić Kirhmajer, Livija Šimičević, Lana Ganoci ... CMJ 61, 147-58, 2020 | 10* | 2020 |
| Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke A Merkler, J Sertić, AB Martinović, T Križ, I Miličić, M Šimić, D Caban, ... Gene 752, 144786, 2020 | 9 | 2020 |
| Prostate specific antigen and type 2 diabetes : A preliminary report. L Cvitković, L Sokolić, I Pavlić-Renar, B Ročić Diabetologia Croatica 30, 121-124, 2001 | 8 | 2001 |
| Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series L Šimičević, AM Slišković, MV Kirhmajer, L Ganoci, H Holik, J Palić, ... Pharmacy 11 (1), 29, 2023 | 6 | 2023 |
| Farmakogenetika/farmakogenomika u personaliziranoj medicini N Božina, L Ganoci, L Šimičević | 6 | 2023 |
| DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand? L Lešnjaković, L Ganoci, I Bilić, L Šimičević, I Mucalo, S Pleština, ... Pharmacogenomics 24 (2), 93-106, 2023 | 6 | 2023 |
| National Guidelines for the Performance of the Sweat Test in Diagnosis of Cystic Fibrosis on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine and … J Leniček Krleža, M Aralica, D Tješić-Drinković, K Crneković, J Culej, ... Biochemia medica 32 (1), 8-23, 2022 | 6 | 2022 |
| Severe hyperglycaemia following pazopanib treatment: The role of drug‐drug‐gene interactions in a patient with metastatic renal cell carcinoma—A case report. D Kuruc Poje, N Božina, L Šimičević, I Žabić Journal of Clinical Pharmacy & Therapeutics 45 (4), 2020 | 3 | 2020 |
| Can the choice of diet undermine the potential genetic risk of AT1R 1166A> C gene polymorphism? T Božina, J Lovrić, L Šimičević, A Merkler, M Božina, B Jelaković, J Sertić Gene 679, 291-296, 2018 | 3 | 2018 |
| Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes. L Šimičević, I Canjuga, L Zibar, A Borić‐Bilušić, L Ganoci, N Božina Journal of Clinical Pharmacy & Therapeutics 47 (9), 2022 | 2 | 2022 |
| FREQUENCY OF AGT, ACE, AGTR1, ADRB1, UMOD AND ADIPOQ GENETIC POLYMORPHISM IN PREHYPERTENSION L Simicevic, B Milicic, J Josipovic, K Djapic, V Domislovic, V Ivkovic, ... Journal of Hypertension (ESH 2019 Abstract Book) 37 (1), e214, 2019 | 2 | 2019 |
| The pharmacogenomics of hypolipemics: ABCG2 as a potential predictor of hepatotoxicity N Božina, L Šimičević, I Pećin, T Božina, Ž Reiner 9. kongres Hrvatskog društva za medicinsku biokemiju i laboratorijsku …, 2018 | 2* | 2018 |
Nada BozinaUniversity Hospital Center Zagreb, Schol of Medicine Zagreb在 kbc-zagreb.hr 的电子邮件经过验证
